Shares of Complete Genomics (GNOM) run up 8.2% premarket on word that the company was selected by the Mayo Clinic to provide outsourced whole human genome sequencing. The collaboration is part of an increasing trend in medicine to analyze the genetic information from consenting patients in order to help provide more efficient medical care.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs